2025 annual financial data
Redhill Biopharma 2025 Operating margin
Redhill Biopharma 2025 operating margin with verified reported values.
Direct answer
Operating margin was -2,765.38%.
Operating income was -7,909,000 USD and net income was -429,000 USD.
Operating cash flow was -9,651,000 USD.
Get free Redhill Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 286,000 USD
- Operating income
- -7,909,000 USD
- Net income
- -429,000 USD
- Operating cash flow
- -9,651,000 USD